Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Biothus
company
About
Biothus is a pharmaceutical company, focused on antibody-based drugs
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥180M
- Industries
- Biotechnology,Health Care
- Founded date
- Feb 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥180M
Biothus has raised a total of
¥180M
in funding over 2 rounds. Their latest funding was raised on
Oct 30, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 30, 2018 | Series A | ¥180M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Biothus is funded by 1 investors.
Zhuhai Huajin Asset
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
